FDA Inspection 1098419 — CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services
The FDA completed an inspection of CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services on Jul 11, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 11, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)